Next in Health: Recent Episodes
PwC's Health Research Institute
A weekly healthcare podcast series hosted by PwC's Health Research Institute that addresses industry trends and timely health policy topics impacting patients, providers, payers, pharmaceutical and life sciences companies as well as vendors and new entrants.
What will healthcare look like a decade from now? Host Glenn Hunzinger is joined by Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader and Thom Bales, Principal, Health Services Advisory Leader, as they dive into the future of health—one driven by smarter tech, empowered consumers, and breakthrough science. From reimagining chronic care to building new business models, discover the mindset, partnerships, and capabilities that will define the next era of healthcare.
Discussion highlights:
- A trillion-dollar shift: who gains and who falls behind
- The rise of the super consumer and personalized care
- Why experience design will become core to life sciences
- How health orgs can prepare with “no regrets” strategic moves
- Collaborating across the ecosystem to drive faster, better, cheaper care
Speakers:
- Glenn Hunzinger, US Health Industries Leader, PwC
- Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC
- Thom Bales, Health Services Advisory Leader, PwC
Linked materials:
From breaking point to breakthrough: the $1 trillion opportunity to reinvent healthcare
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, sits down with Nichole Montgomery, Shannon O’Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of the bill dedicated to healthcare, the team explores how this landmark legislation will reshape coverage, funding, and delivery across the payer, provider, and pharma landscape.
Discussion highlights:
- The OBBBA introduces new work requirements and eligibility rules that could lead to coverage loss for over 13 million people, placing new burdens on payers and states
- Providers face increased uncompensated care, especially in rural areas, with added administrative complexity and a push toward technology and alternative care models
- Payers are bracing for membership loss, reduced Medicaid funding, and increased administrative load as new eligibility rules take effect
- Pharma may see reduced demand from public programs but gains through an orphan drug exemption and incentives for domestic manufacturing
- The bill’s sweeping changes will disrupt healthcare, but with foresight, organizations can model financial impact, prepare for operational disruption, and plan strategic responses
Speakers:
- Glenn Hunzinger (host), Health Industries Leader, PwC
- Shannon O'Shea, Principal, Health Transformation, Provider Clinical Transformation, PwC
- Phil Scalfani, Principal, Customer Transformation, Pharmaceutical & Life Sciences, PwC
- Nichole Montgomery, Principal, Health Transformation, Health Services, PwC
Linked Materials:
https://www.pwc.com/us/en/industries/health-industries/library/impact-of-obbba-on-us-health-system.html
https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Nick Donkar, PwC’s U.S. Health Services Deals Leader, and Roel Van den Akker, PwC’s Pharma and Life Sciences Deals Leader, to discuss the 2025 midyear deals outlook across health services and pharma and life sciences. They explore how macroeconomic trends, regulatory pressures, and evolving investment strategies are shaping M&A activity and where new opportunities may emerge as companies look ahead to the second half of the year.
Discussion highlights:
- Health services deal volume remains resilient, with renewed investor interest in behavioral health, physician groups, and home-based care models
- Private equity firms are focused on outpatient growth platforms and niche services like revenue cycle management to navigate cost and regulatory headwinds
- Pharma and life sciences dealmaking is centered on targeted, asset driven M&A in the $1 to $5 billion range, rather than full scale platform acquisitions
- Regulatory uncertainty from FDA resource constraints to evolving policies on pricing and probability of technical and regulatory success (PTRS), is complicating deal modeling and slowing transaction timelines
- U.S. biopharma companies are increasingly sourcing early stage innovation from China, introducing new strategic opportunities along with cross border compliance and data challenges
Speakers:
Glenn Hunzinger, Health Industries Leader, PwC
Nick Donkar, US Healthcare Deals Leader
Roel Van den Akker, US Pharma & Life Sciences Deals Leader
Linked materials:
https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, and Phil Scalfani, PwC’s Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration’s executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healthcare ecosystem. They break down what MFN pricing could mean for pharmaceutical companies, payers, PBMs, and the broader drug supply chain, and share perspectives on how organizations can navigate the uncertainty ahead.
Discussion Highlights:
- The MFN executive order is a bold attempt to lower U.S. drug prices by benchmarking them against the lowest prices paid in other high-income countries
- Pharma companies may be forced to rethink global pricing strategies, balancing U.S. price cuts with potential increases or market exits abroad
- A proposed shift to direct-to-consumer drug access could disrupt traditional roles for pharmacies, distributors, and pharmacy benefit managers (PBMs)
- Companies are preparing for significant uncertainty by reassessing deals, modeling financial impacts, and closely monitoring upcoming rulemaking and potential legal developments
Speakers:
Glenn Hunzinger, Health Industries Leader, PwC
Philip Sclafani, Partner, Pharma & Life Sciences, PwC
Linked materials:
Most Favored Nation prescription drug pricing Executive Order
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Matt Rich, PwC’s Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in the face of regulatory uncertainty, avoid preventable delays, and take practical steps to move programs forward with clarity.
Discussion highlights:
- Ongoing restructuring at the FDA is creating uncertainty and delays in drug and device approvals, with wide-ranging impacts across the pharma, biotech and medtech landscape.
- While companies can’t control the regulatory environment, they can focus on improving internal speed, efficiency, and submission quality to keep programs moving forward
- Avoiding preventable missteps, or “foot faults,” in data, endpoints, and submission packages is critical to reducing review delays and regulatory pushback
- Diversifying risk by pursuing parallel regulatory pathways in other regions such as Europe and Japan can help accelerate access and reduce dependency on a single agency
- In the absence of a clear playbook, companies should focus on what they can control by applying past lessons, staying disciplined, and collaborating across the industry to support more efficient FDA review processes
Speakers:
Matt Rich, PwC’s Pharmaceutical and Life Sciences R&D Leader
Glenn Hunzinger, Partner, Health Industries Leader, PwC
Linked materials:
Navigating the FDA disruption: 4 key actions for pharma
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader and Roel van den Akker, PwC’s Pharma and Life Sciences Deals Leader discuss the rapid rise of China’s biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech in the global innovation landscape and share perspectives on how U.S. pharmaceutical companies can thoughtfully assess opportunities, manage cross-border complexities, and build effective partnering and diligence strategies.
Discussion highlights:
- China’s biotech industry is growing fast and becoming a global player, with U.S. companies increasingly looking to partner with Chinese firms on cutting-edge science
- U.S. pharma leaders are encouraged to move beyond skepticism and stay curious by building relationships, learning from local innovation, and exploring new partnership opportunities
- Successfully partnering with Chinese biotech firms requires a careful and well-structured approach that accounts for global complexity, protects data and IP, and uses creative deal structures like new company formations to manage risk and stay flexible
- U.S. companies need to be proactive in order to stay competitive by actively exploring global innovation, understanding the risks, and having a clear strategy to bring high-potential science to U.S. patients
Speakers:
Roel Van den Akker, Pharmaceutical and Life Sciences Deals Leader
Glenn Hunzinger, Partner, Health Industries Leader, PwC
Linked materials:
China's rise as a biotech innovation hub: 4 key strategic questions for US biopharma executives
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Disclaimer: This episode was recorded on April 11th, 2025, and reflects the information available at the time of recording. As we know, America is in motion here, and so subsequent updates may not be reflected in this discussion as things continue to evolve and change.
Tune in as PwC specialists from across the health industry share their insights on how recent policy shifts under the Trump administration could shape healthcare in the years to come. In this episode, Glenn Hunzinger, Jenny Colapietro, and guests Kelly Griffin, Phil Sclafani, and Ruchita Kewalramani break down the potential implications of proposed government healthcare cuts, tariff policy and agency workforce reductions, along with the growing role of AI in the industry. They also discuss how pharma, medtech, payers and providers can stay ahead amidst the uncertainty.
Discussion highlights:
- Proposed funding cuts to major government healthcare programs like Medicare, Medicaid, and NIH could significantly disrupt access, affordability, and service delivery across the healthcare landscape.
- Workforce reductions at federal agencies like the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Health and Human Services (HHS) may slow drug approvals, diminish oversight, and impact public health standards.
- New and evolving tariff policies are creating cost pressures across pharmaceutical and medtech supply chains, with potential downstream impacts on pricing, R&D, and patient access.
- The rapid adoption of AI in healthcare is creating new opportunities across diagnostics, R&D, and operations, while also raising concerns around governance and data privacy.
- To stay ahead, industry leaders must assess risks, strengthen agility, and uncover opportunities to innovate in today’s dynamic environment.
Speakers:
Kelly Griffin, Director, Health Policy Intelligence Institute, PwC
Ruchita Kewalramani, Partner, Health Services PwC
Phil Sclafani, Partner, Pharma & Life Sciences, PwC
Glenn Hunzinger, Partner, Health Industries Leader, PwC
Jenny Colapietro, Principal, Consulting Commercial Leader, PwC
Linked materials:
Health Policy and Intelligence Institute
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights:
- Understanding the scale and implications of the upcoming patent cliff and economic pressures from regulatory changes like the Inflation Reduction Act
- Examining heightened competition across therapeutic areas and the rapid emergence of rival treatments affecting market economics
- Highlighting the necessity for bold strategic moves and critical capabilities, including AI innovation, portfolio optimization, strategic partnerships, and comprehensive risk management
- Addressing disruptive forces such as geopolitical uncertainty, tariff impacts, and the rise of global innovation influencing pharmaceutical markets
- Emphasizing the urgency for pharma leaders to embrace innovation and transformative strategies to improve healthcare affordability, accessibility, and quality
Speakers:
Greg Rotz, Pharmaceutical & Life Sciences Leader,PwC
Glenn Hunzinger, Health Industries Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
Next in pharma 2025: The future is now
Pharmaceutical and life sciences: US Deals 2025 outlook
President Donald J. Trump’s healthcare agenda
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability.
Topics include:
- Medicare and Medicaid drive industry growth amid rising competition, market exits, M&A, AI adoption, and policy challenges.
- AI's potential to enhance healthcare delivery, improve workforce management, and optimize patient care.
- The care-at-home market is growing rapidly, driven by demand and cost efficiency, but sustainability remains a challenge.
- Encouragement for healthcare organizations to adapt and innovate in response to policy shifts and technological advancements.
Speakers:
Thom Bales, Health Services Leader, PwC
Alena Taylor, Principal, PwC
Ruchita Kewalramani, Principal, PwC
Glenn Hunzinger, Health Industries Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
- Next in Health: The 2025 Outlook for Health Services: https://www.pwc.com/us/en/industries/health-industries/library/healthcare-trends.html
- Health Policy and Intelligence Institute: https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:
Key topics include:
- A look back at M&A activity in health industries in 2024
- The challenges and potential impediments that could affect deal volumes in the coming year
- How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
- Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors
Speakers:Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
- https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
- https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as authors of PwC's U.S. Healthcare Climate Survey discuss key findings and provide insights into understanding healthcare organizations' responses to climate change, the integration of climate strategies, and the challenges faced in implementation.
Key topics include:
- The survey's background, focus, and objectives that address the prioritization of climate strategies by healthcare organizations in response to climate change impacts
- Differences in climate strategy approaches across sectors, reveals significant disparities in priorities and operational needs amongst payers, providers, pharmaceutical, and medtech companies
- Key statistics and insights on organizational behavior and perceptions related to climate strategy integration, sustainability, and the impact on human health
- Considerations for healthcare stakeholders to enhance climate strategy implementation and address the evolving needs of diverse communities affected by climate change
Speakers:Mackenzie Daly, Partner, PwC
Stacie Gitkin, Director, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
https://www.pwc.com/us/en/industries/health-industries/library/impact-of-climate-change-on-human-health.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as authors of PwC's U.S. Healthcare Consumer Insights and Engagement Survey discuss key findings and provide insights into understanding consumer concerns around healthcare costs, the adoption of tech-enabled healthcare, trust in the healthcare system and how we can take action.
Key topics include:
- The survey's background, focus and objectives that will address ongoing consumer concerns and distrust in the healthcare system
- Generational and financial differences reveal significant disparities in healthcare experiences and engagement amongst various age groups
- Notable key statistics and insights on consumer behavior and perceptions related to trust, affordability, delayed care and digital health across the health ecosystem
- Considerations for healthcare stakeholders to enhance care delivery and to address the evolving needs of diverse patient populations
Speakers:
Thom Bales, Health Services Leader, PwC
Keith Fengler, Customer Service and Channels Lead, PwC,
Omar Chane, Principal, PwC.
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
https://www.pwc.com/us/en/industries/health-industries/library/healthcare-consumer-insights-survey.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
How can medtech companies drive growth in today's market? Tune in as PwC specialists return to share key insights and strategies to help medtech companies invest in the capabilities required to compete in the future while aiming to exceed near-term expectations for growth and margin improvement.
Key topics include:
- Challenges currently faced by medtech companies
- Reevaluating business models and new ways to play
- Driving returns on historical investments in technology by leveraging data and transforming legacy processes
- Embracing a “high-tech” mindset to enable change and creating a culture of empowered decision makers
- Unlocking value through strategic M&A
Speakers:James Woods, Principal, PwC
Kevin McLellan, Principal, Strategy&, PwC
Luna Corbetta, Principal, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Materials:
https://www.pwc.com/us/en/industries/health-industries/medical-technology/medtech-industry-insights.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
What can the health industry expect from a second Trump administration? Tune in to hear what executives should watch over the next few months and years to come.
Key topics include:
- President-elect Trump's healthcare agenda and his focus on deregulation, flexibility and choice, and accessibility
- Potential implications for medicare, the ACA and IRA drug negotiations
- What to watch in the first 100 days
Speakers:Kelly Griffin, Director, Health Policy and Intelligence Institute
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
https://www.pwc.com/us/en/industries/health-industries/library/election-2024-trump-health-agenda.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as PwC specialists discuss best practices for securing a seat on an emerging company board.
Key topics include:
- Types of emerging companies
- Responsibilities of serving on emerging company boards
- Five strategies for securing a board position
- Importance of industry-specific expertise and continuous learning
Speakers:Holly Reeves, Partner, Emerging Company Solutions Market Leader, Health Industries, PwC US
Carin Robinson, Director, Governance Insights Center, PwC US
Jenny Colapietro, Consulting Commercial Leader, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as authors of PwC's 2025 Medical Cost Trend Report: Behind the Numbers, discuss key findings and provide what employers should consider to manage rising healthcare costs.
Key points include:
- Cost projections: The highest medical cost trend in 13 years, with an 8% increase for the group market and 7.5% for the individual market
- Key drivers: Inflation, providers' cost-control efforts, increased use of prescription drugs, and new innovative therapies
- Strategic adjustments: Employers should revise benefit plans and consider innovative solutions to manage rising costs while ensuring access to quality care
Speakers:Thom Bales, Health Services Advisory Leader, PwC
Phil Sclafani, Principal, Pharmaceutical and Life Sciences, PwC
Julian Levin, Principal, Actuarial Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as PwC specialists discuss how emerging companies (private, pre-IPO) are navigating growth in the health industry.
Key topics include:
- The journey and milestones of emerging companies in the life sciences, biotech and medical technology fields, including capital raising, product development and IPO preparation
- Common pitfalls and best practices for managing diverse interests from investors and stakeholders
- Examples of how emerging companies are leveraging AI and other technologies to prioritize programs, design clinical trials and communicate value proposition
Speakers:Holly Reeves, Health Industries - Emerging Company Solutions Market Leader, PwC US
Christian Jester, Technology, Media & Telecommunications - Emerging Company Solutions Market Leader, PwC US
Jenny Colapietro, Health Industries Vice Chair, PwC, US
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as PwC specialists discuss the 2024 outlook for healthcare and how the sector can grow and innovate amid economic challenges and uncertainty.
Key Topics include:
- Major forces impacting the sector: economic pressure, rising costs, labor shortage, and expensive drugs
- Ways to overcome compression and deliver value: industry-wide transformation, tech enabled business model reinvention, transactions and deals to drive transformation, and building trust
Speakers: Laura Robinette, Health Industries Trust Solutions Leader, PwC, US
Thom Bales, Health Services Leader, PwC, US
Jenny Colapietro, Health Industries Vice Chair, PwC, US
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry.
Key topics include:
- The headwinds for pharma are real and sustained
- Rethinking the innovation strategy
- Accelerate using AI and analytics
- Lower costs
- M&A as a catalyst for transformation
- Protecting the enterprise
Speakers:
Jenny Colapietro, Health Industries Vice Chair, PwC
Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwC
Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include:
- Fundamental changes and strategy trends for 2024 and how it’s shaping the health services and pharma landscapes
- The role of the regulators and their impact on deals
- Business model reinvention and the use of new technology to acquire better data and how it’s shaping the deals environment for 2024
- What’s on the horizon: Key success factors for good deal making in 2024
Speakers:Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how health ecospheres can provide a transformative model for organizations to collaborate and address large-scale healthcare problems. Topics include:
- Identifying areas of historical shortcomings
- Understanding strengths and capabilities
- Determining the role within the ecosphere
Speakers:
Dave Powell, Enterprise Strategy Lead Principal, PwC
Tyler Mansfield, Enterprise Strategy Principal, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in as health leader, author and entrepreneur, Stephen Pollak, PhD, shares how the outcomes of his research in hemodialysis populations and beyond are paving the path for data-driven solutions that inform and integrate care for patients with complex chronic conditions. Topics include:
- Patient medical records playing a vital role in improving medical practice outcomes and costs
- Shifting the focus to emphasize on a results-oriented approach to inform decision-making
- Overcoming sustainability and affordability challenges through clinical models
- The role of AI in healthcare
Speakers:
Stephen Pollak, PhD
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss re-engineering the healthcare ecosystem by engaging healthcare consumers. Topics include:
- Evaluating the consumer experience and engagement
- Trends in the market to help organizations develop and focus on their mission to enhance consumer experience and key investments
- Three capabilities that are needed to deliver on the promise of personalization, low cost, experience, and convenience
Speakers:
Derek Gaasch, Customer Transformation Principal, PwC
Elizabeth Carlson, Customer Transformation Director, PwC
Kristen Knudson, Enterprise Transformation Senior Manager, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Barrett Baker of Project Horizon from the Sunflower Network, and Dan Solchanyk from Razom, discuss how to strengthen Ukraine’s healthcare infrastructure both for the near and the long term. Topics include:
- Sunflower Network’s mission is to deliver aid and infrastructure to communities in crisis. Project Horizon furthers this mission by building a hospital in Ukraine, empowering local healthcare workers with the infrastructure needed to deliver high quality care to their patients, and setting the stage for a larger rebuild of Ukraine’s healthcare system
- Razom Health: Providing critical supplies, equipment, training and preparing for long-term sustainability
- Challenges and strategies to find the right balance between speed, providing high quality enduring solutions, and mitigating risks
- Examples of how determination and perseverance of the Ukraine communities are pioneering innovative healthcare solutions
Speakers:
Barrett Baker, Project Lead, Sunflower Network
Dan Solchanyk, Program Director, Razom Health
Igor Belokrinitsky, Strategy& Principal, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Chris Barnett, Chris Barnett, CEO of ABA Centers of America, discuss his approach to a comprehensive healthcare system, with a specific emphasis on new models, technologies, and algorithms that promote inclusivity for improved behavioral health care outcomes. Topics include:
- The origin of Applied Behavioral Analysis (ABA) and how it seek to change lives by helping change behavior of patients on the spectrum, improving their lives and those around them.
- Examples of offering play-based therapies to achieve better outcomes and experiences for patients that are non-verbal
- Challenges and issues faced in the behavioral health space and solutions to help prevent workforce burnout and increase benefit options for staff
- How ABA is using AI and technology to gain better data and insights
Speakers:
Chris Barnett, CEO, ABA Centers of America
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:
- Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese market
- Three approaches organizations can consider to competing at a local level in China
- Impacts to different functions across the value chain such as R&D, supply chain, and IT
Speakers:
Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC
Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
People across the world are suffering from behavioral and mental health challenges. Tune in to hear Eric Hren, Chief Growth Officer at Innowell, discuss how technology can help provide better services and solutions for patients, clinicians and employers. Topics include:
- Getting to know Innowell: What it does, what it offers, and the problems it solves
- Reaching various populations by increasing digitization to improve wellbeing and productivity, providing real-time care and reducing waitlist time
- Designing technology to be inclusive across all populations as well as accessible to various care settings
- Future growth of Innowell: Providing preventative care and solutions to unlock better outcomes for patients, clinicians, and organizations
Speakers:Eric Hren, Chief Growth Officer, Innowell
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss the functionality and benefits of using GenAI in health care. Topics include:
- How GenAI is being used today
- GenAI helping health insurers drive affordability of healthcare
- Health organizations managing risks posed by GenAI
Speakers:
Inshita Wij, Strategy& Director, PwC
Sri Murthy, Strategy& Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss using GenAI in the pharma and life sciences industry. Topics include:
- Key considerations for new technology and deploying GenAI responsibly
- Key elements to consider for monitoring regulatory activity
- The future of technology, adoption and upskilling within organizations
Speakers:Siddhartha Bhattacharya, Cloud & Digital Principal, PwC
Ilana Golbin Blumenfeld, Products & Technology Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear how the SCAN Group is expanding their Medicare Advantage plan by launching new care entities that aim to address problems of older adults. Topics include:
•Addressing national-scale industry issues such as affordability and equity, and the role SCAN Group is playing
•How attributes and mindset make the legal department a great fit to oversee health equity
•Initiatives and data-driven solutions to help close the gap around racial disparities
•What’s next for the SCAN Group: New affiliations, products, and innovation
Speakers:Sachin Jain, M.D., CEO, SCAN Group
Renee Delphin-Rodriguez, Chief Legal Office and General Counsel, SCAN Group
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how life sciences companies are engaging better with consumers and patients and rethinking engagement, the channels utilized and how to utilize data and technology to create meaningful impact. Topics include:
•What elements create a good customer experience and why it’s important
•Four key principles to creating a good customer experience
•Restructuring roles and focus in commercial and medical organizations as well as identifying organizational growth
•Utilizing data and technology along with the new evolution of Generative AI
Speakers:
Elizabeth Otterman, Customer Strategy and Insights Principal, PwC
Jacquie Newland, Services and Channels Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the deals landscape 2023 and offer a preview of what lies ahead. Topics include:
- A look back at M&A activity in health industries so far in 2023
- The future of deals: The role of regulators, shareholders, and private equity in the health space
- Three areas to keep an eye on: potential legislative or tax changes, stabilization of debt markets and interest rates, and strong data sets
Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Robbie Pottharst, CEO of myPlace Health, discuss their mission for building a health care startup to integrate better care for the elderly. Topics include:
- What is the PACE model?
- How myPlace Health works with sponsors to develop comprehensive plans and services covering areas such as behavioral health, clinical pharmacy, palliative care, and technology innovations that tackle social frailty and isolation
- Role of a startup in solving important problems in healthcare
Speakers:
Robbie Pottharst, CEO, myPlace Health
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear how incorporating immersive technology in healthcare opens new frontiers; enabling patients to embark on transformative virtual health journeys to enhance their outcomes and user experience. Topics include:
- Examples of the use of immersive technology and future possibilities as technology advances
- Patient navigation of an acute visit: A turn-by-turn tour to provide the patient with knowledge and understanding while creating a confident and comfortable environment
- Getting started: How companies can leverage the power of immersive technology within their companies
Speakers:
Patrick Maher, Strategy& Principal, PwC
Ryan Caruso, Director of Emerging Technologies, PwC
Aparna Kumar, Director of Healthcare Provider Strategy, PwC
Lily Shay, Manager, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear what pharma stakeholders should know about the implementation of the Drug Supply Chain Security Act. Topics include:
- The objective of the Drug Supply Chain Security Act and timeline
- Steps pharma stakeholders need to take to be D.C.S.A compliant and how to prepare
- Readiness checklist: Four key tips to planning
- Perspectives on preparation from Walgreens
Speakers:Pat Lupo, Vice President of Pharmacy and Specialty Trade, Walgreens
Namit Mehta, Principal, Operations Transformation, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear how pharmaceutical and life sciences companies are shifting their interactions with healthcare providers to consolidate outreach and streamline compliance using chat platforms. Topics include:
- Benefits of communicating with HCPs as a team through a single portal, including sales, medical sales liaisons, and access specialists
- Maintaining the appropriate compliance processes to build trust and transparency
- Driving better relationships between medical science liaisons and Key Opinion Leaders (KOLs)
- Use cases and outlook for Flex Connect
Speakers:
Katherine Buckley, Principal, Regulatory Risk and Compliance, PwC
Tyler Jorgensen, Principal, Customer Transformation, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Dr. Ari Hoffman, Chief Clinical Officer at Collective Health, discuss how they are changing the way people experience their health benefits by making it easier to understand, navigate, access, and pay for healthcare. Topics include:
- The process for building a workforce health benefits platform that aims to achieve better health at lower costs
- Customizing benefit plans and providing a better understanding of the system for members
- The power of digital tools and data analytics to optimize engagement, participation, and behavioral change
Speakers:
Dr. Ari Hoffman, Chief Clinical Officer, Collective Health
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear perspectives on how healthcare organizations can be more resilient and prepared for the next pandemic. Topics include:
• What healthcare organizations are doing to better prepare for the next pandemic.
• Key players within the ecosystem and how they need to collaborate to gain efficiencies across the value chain.
• What organizations are doing to build their speed and their scale to be able to move when the time comes.
Speakers:
Omar Chane, Life Sciences Commercial Practice Principal, PwC
May Weiser, Pharmaceutical and Life Sciences Director, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Charles Jones, Vaccine Industry Leader at Pfizer, discuss the future of vaccines in the marketplace. Topics include:
- Changes seen in the marketplace and the competitive landscape
- Challenges of the changing schedule for preventative products such as flu immunization, COVID-19, Pneumococcal, shingle vaccines, and more
- The role of policy makers, like The Advisory Committee on Immunization Practices (ACIP) in the US and all the various participants, and the impacts they have on the value chain and the future of the ecosystem
Speakers:
Charles Jones, Vaccine Industry Leader, Pfizer
Amy Hunckler, Pharma and Life Sciences Managing Director, PwC
May Weiser, Pharma and Life Sciences Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how advanced analytics are helping health payers use new tools to forecast and improve outcomes, experience and costs. Topics include:
- Improving affordability, quality and experience through more timely and actionable forecasting
- Data science and technology to make it possible
- Moving to implementation
Speakers:Sachin Bajpai, Healthcare Data and Analytics Director, PwC
John Kiley, Data Scientist Senior Manager, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Cardinal Health’s President of Nuclear and Precision Health Solutions, Mike Pintek, discuss the potential of nuclear medicine and theranostics advancements in precision healthcare. Topics include:
- How nuclear imaging is being used to provide better insights into the diagnosis of Alzheimer's disease and new treatment therapies going forward
- Advancing strategic sourcing to strengthen the supply chain by enhancing operational resiliency
- Supporting access to new products and advancing precision healthcare, including the focus on theranostics strategy
Speakers:
Mike Pintek, President of Nuclear and Precision Health Solutions, Cardinal Health
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear TeamBuilder’s David Howard and Mea Parikh discuss how healthcare organizations can leverage digital technology to improve staffing and scheduling. Topics include:
- The concept and evolution of Team Builder
- The transition to help organizations solve broader industry challenges related to labor
- Highlights of what providers find more useful and effective
- Lessons learned from getting caregivers and administrators to change the way they work while building trust
Speakers:
David Howard, Founder & CEO, TeamBuilder
Mea Parikh, Head of Operations, TeamBuilder
Jenny Colapietro, Health Industries Vice Chair, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how focusing on ESG strategies can help enhance business growth, value, and harness workforce innovation. Topics include:
•How organizations can prioritize their focus on ESG strategy to enhance their business goals
•The role of ESG in deals across the industry
•The use of technology to measure reporting and impact of ESG
•Aligning ESG strategy to workforce culture and values
Speakers:
Pete Regis, Assurance Partner, PwC
Brian Henry, ESG Transformation Managing Director, PwC
Wayne Lombardi, ESG Health Services Digital Assurance and Technology Principal, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how life sciences organizations can innovate better despite margin pressure and uncertainty. Topics include:
•Recalibrating R&D spend to speed innovation
•Aligning across the value chain (sales, R&D, supply chain) to support new innovation
•Driving creativity as well as discipline to align the innovation strategy to the overall enterprise strategy
Speakers:
Andy Ogrins, Strategy& Director, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear Alan Weil, Editor-in-Chief at Health Affairs, discuss what drives and improves disparities in health care. Topics include:
- Defining social determinants of health
- 3 building blocks to addressing inequality: Improve communities, social responses, and ROI
- The role of governance: Decision-making, measuring ROI, allocating resources
Speakers:
Alan Weil, Editor-in-Chief, Health Affairs
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in for a discussion with Minal Patel, founder and CEO of Abacus Insights, on the challenges and promises of cloud transformation in healthcare. Topics include:
- DOT connector framework: leveraging technology to bring data together for analytics and other operational purposes.
- Challenges from an organizational, transformational, and technology perspective.
- Guidance for companies interested in improving their data usage.
Speakers:Minal Patel, Founder and CEO, Abacus Insights
Ravi Kalakota, Managing Director, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how PwC's digital products are helping to solve critical challenges across the health care industry. Topics include:
- Digital transformation outlook and trends across the industry
- PwC's innovative solutions and products such as, Interactions Hub, Transparency Hub, Flex Connect and more
- How digital transformation is improving quality, equity, and affordability
Speakers:
Rachel Moore, Products & Technology Director, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to hear PwC specialists discuss how new technology and sharing frontline experiences of nurses are helping to overcome challenges across health care organizations. Topics include:
- Implementing digital tools, apps, hybrid delivery models, and digital preference cards
- Managing labor shortages, providing more affordable care and focusing on accessibility
- Strategy and results for implementing new technology tools in digital health organizations
Speakers:
Alena Taylor, Strategy& Principal, PwC
Patrick Voight, Clinical Transformation Managing Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear Denver Wallbrown, Exponential AI’s Senior Vice President of Customer Success and Delivery, and PwC specialists discuss how new technology is helping to identify revenue leakage within the entire revenue management cycle of life sciences companies. Topics include:
- Three lifecycles that help determine where companies need support when identifying areas of revenue leakage
- Artificial Intelligence solutions used for real-time decisioning to make human-like decisions and solve revenue leakage problems
- Realize the true value of AI to help solve business challenges across the value chain
Speakers:Denver Wallbrown, Senior Vice President of Customer Success and Delivery, Exponential AI
Steve Foran, Pharmaceutical and Life Sciences Managing Director, PwC Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear Troy Smith, Blue Cross and Blue Shield of North Carolina's Cost of Care VP, discuss the importance of making healthcare more affordable through a variety of value-based care models. Topics include:
- The state of value-based care models and how they are evolving, implemented, and measured.
- Shifts from incentive to downside risk models and how healthcare is being delivered to diverse populations.
- Managing challenges and risks of these models such as creating contracts and standardizing quality.
SpeakersTroy Smith, Cost of Care Vice President, Blue Cross and Blue Shield of North Carolina
John Andrewes, Strategy& Principal, PwC
Tori Fancher, Clinical Transformation Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear PwC specialists discuss key topics for improving health organizations’ performance and transformation in 2023. Topics include:
- Defining the six chronic issues in healthcare
- Greater affordability and the role of digital
- Solving systemic clinical workforce shortages
Speakers
Thom Bales, Principal, Health Services Consulting Solutions Leader, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
Click here to read the Next in health services 2023 Outlook report
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
In our Next in Health podcast, PwC specialists dive into four areas the pharma c-suite should focus on to thrive in 2023. Topics include:
- Impacts and adjustments resulting from the Inflation Reduction Act
- Strategies companies can use to deal with cost pressures while driving value
- How digital technologies are helping to empower growth and differentiation across the value chain
- Expectations for M&A in 2023
Speakers
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
Glenn Hunzinger, Pharmaceutical and Life Sciences Consulting Leader, PwC
Greg Rotz, Pharmaceutical and Life Sciences Transformation Leader, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
In our Next in Health podcast, PwC specialists share their perspectives on healthcare staffing shortages, ways to address them, and lessons learned. Topics include:
- Building trust and engaging with the nursing and healthcare communities in new and different ways
- Day-to-day staffing and evolving education/training
- Reinvention of the job/career model and implementing recommendations
- Finding the right balance between putting out fires and long-term rebuilding
Speakers:
Kathryn Burg Plaza, Clinical Leader, PwC
Alyson Simonetta, Higher Education Leader, PwC
Aparna Kumar, Director, Workforce Strategy and Training, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
In this podcast, PwC specialists discuss the risks, considerations, and success strategies for pharmaceutical and life sciences companies to best operate in the China market. Topics include:
- Opportunities and trends in the China market
- Elements of an effective and successful strategy
- Challenges and risks for organizations to be mindful of as it enters and operates in the China market
- R&D manufacturing helping to increase the education of the workforce
Speakers:
Nalneesh Gaur, Cyber Risk and Regulatory Partner, PwC
Ben Rhee, Enterprise Strategy and Value Principal, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
In this podcast, PwC specialists discuss adding health equity to the quintuple aim and how it can improve health outcomes for all communities, while saving on future costs for health organizations. Topics include:
- The evolution towards hospitals and health systems of the futures on quality experience, and cost
- Shifting focus from sick care to helping patients access healthcare in a way that is more individualized
- Health organizations using data to determine the right capabilities in the business, in their people, and in technology to avoid future costs and poor outcomes
Speakers:
Igor Belokrinitsky, Strategy& Principal, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Trisha Swift, Strategy & Managing Director, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into PwC's Next in Health for an overview of the history of the revenue cycle and what’s ahead. Topics include:
- The history of the revenue cycle
- People strategy: How to retain good people
- Seeing ROI when implementing new technology
- Using data in a more sophisticated way to help identify pain points
Speakers:
Jacob Shurbet, Managing Director, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into PwC's Next in health for a discussion of lessons learned from deals in 2022 and what we can expect in 2023 and beyond. Topics include:
- Increase in M&A that’s more aligned to previous years
- Rethinking strategies and increasing innovation
- The important role of Private Equity
- Inflation Reduction Act implications
Speakers:
Nick Donkar, US Health Services Deals Sector Leader – Partner, PwC
Roel Van Den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Host: Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into PwC’s 100th podcast episode of Next in Health to hear about the experiences leading us towards the evolution of hospitals and health systems of the future. Topics include:
- Collaboration both internally and with providers
- Rethinking capital investments
- Hybrid delivery model and digital transformation
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into PwC's Next in Health for a discussion on how Arise Health is working to provide inclusive and comprehensive care for eating disorders and mental health. Topics include:
- Looking at sociocultural factors and underlying needs in an inclusive way
- Centering the experiences of those who haven't been seen or validated
- Seeking to create a health system that allows for more accessible and personalized care
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear about the role of privacy and security in healthcare organizations and what leaders need to know. Topics include:
- Strategies to build an automated and sustainable privacy and security program that serves patients while also meeting business objectives
- Exploring data risk and privacy issues and considerations
- Use of assets, and how best to plan, design, and manage risks
- Privacy by design
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear PwC’s Igor Belokrinitsky and Millennium Physicians Group Corey Cines, discuss how to empower primary care physicians to invest in creating better patient experiences. Topics include:
- Constant innovation to the current model
- Specific arrangements for geographic markets
- Use of technology in creating great experiences and delivering value
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear PwC specialists discuss what’s next for the Medicare customer: Topics include:
- Plan choices, and the diversity of the customer’s needs
- Ensuring the right mix of digital and other channels
- Transitioning from a commercial to a Medicare Advantage health plan
- Focus areas for building health plan operating models
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in Health to hear PwC specialists discuss key stages and implications for industrializing healthcare. Topics include:
- The notion of ecosystems and whether you're an incumbent or a disruptor
- Productization and how it helps create clarity around pricing, quality, experiences, safety, and equity
- The potential of technology to transform healthcare
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in health to hear PwC specialists discuss virtual first health plans. Topics include:
- Benefits, services and impacts
- Adoption
- Creation
- Educating and providing new marketing programs and strategies for payers and providers
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune in to PwC’s Next in health to hear how Innovaccer’s leading data and analytics platform is helping to shape the transformation of healthcare. Topics include:
- A 360 view inside a patient’s financial data, clinical information, and demographic information all in one platform
- Leveraging new programs such as ACO reach, and value-based care programs in order to keep patients at the center of the healthcare ecosystem
- Three key components for data readiness in value-based care
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in health to hear PwC Strategy& Principal Igor Belokrinitsky, Director Elena Pretto, and Deals Principal and Medtech Leader James Woods, discuss the forces shaping the future of medtech. Topics include:
- Various forces shaping the industry including care settings, patient empowerment, provider burn out and reimbursement
- How medical technology companies can think beyond digital
- Three business models and growth strategies for medical technology companies to consider for the future
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in health as we are joined by David Levy, PwC Alum, CEO of EHE Health, share how EHE Health is shaping the health platform differently by focusing on preventive health, value-based care, and the clinician experience. Topics include:
- How EHE is targeting preventative health to make it more effective
- Improving the clinician's experience and how this is impacting care to the consumer
- Participating on the various value-based care models and where they are headed
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in health to hear PwC Strategy& Principal Igor Belokrinitsky, joined by PwC’s Health Industries Vice Chair Jenny Colapietro, Workforce Transformation Principal Luna Corbetta, and Global Leader for Strategy and Leadership Blair Sheppard, discuss how culture and leadership are helping to accelerate and transform the pharma industry. Topics include:
- Four key building blocks that bring purpose
- Building trust and driving innovation
- Demonstrating leadership behavior and balancing culture to make it immediately practical
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with the Founder & CEO of Millie, Anu Sharma, on modernizing maternity care, including:
- The current challenges in maternal health services
- Millie’s mission to improve access to quality maternity care
- Bridging the gaps behind maternal health disparities
- Implications of the Supreme Court's ruling on maternal health care
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in health to hear Strategy& Principal Igor Belokrinitsky, joined by PwC’s Health Industry Trust Solutions Leader, Laura Robinette, Customer Pricing and Profitability Partner, Philip Sclafani, and Corporate Tax Generalist Partner, Ben Proce discuss the Inflation Reduction Act and the key provisions that will impact health industries. Topics include:
- Drug pricing reform and timelines
- New inflationary rebates for Medicare and the expansion for patient access, eligibility, and affordability
- Corporate alternative minimum tax, fair market value and tax implications
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, joined by PwC's Partner, Sreekumar Krishnamony and Director, Shuting Shao, discuss how advances in cloud computing and technology are playing a crucial role in at home health care. Topics include:
- The benefits of tech-enabled care at home models.
- The ability to process and analyze data streams.
- What organizations need to be mindful of when adding technology to home health care models.
- Four capabilities to build a new infrastructure.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Strategy&'s Patrick Maher and Inshita Wij, on how connected health ecosystems can help hospitals drive more equitable health outcomes while improving the experience for patients and care teams, including:
- Helping hospitals understand their biggest challenges and threats and identify growth opportunities
- Increasing physician ownership and participation
- Identifying key digital and technology partnerships
- Getting ahead of an increasingly complex portfolio of competitors
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, PwC Health Industries Vice Chair, Jenny Colapietro, PwC Pharmaceutical and Life Sciences Consulting Leader, Glenn Hunzinger, and PwC Pharmaceutical and Life Sciences Transformation Leader, Greg Rotz, discuss the current state of the sector and what's next for the pharmaceutical industry, including:
- Top challenges the pharma industry is facing today
- Five key actions companies can take to outperform competition
- Harnessing the full power of digital and cloud capabilities
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, PwC Health Industries Vice Chair, Jenny Colapietro and Dr. Rouzbeh Ahmadian talk about transformative mergers between health systems and the impact on stakeholders in the communities they serve, including:
- Impact of deals on the quality and price and health equity in communities
- Deal structure and post integration, planning, and stakeholder management
- Addressing stakeholder concerns
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear hosts Strategy& Principal, Igor Belokrinitsky, Health Industries Vice Chair, Jenny Colapietro and PwC guests Principal Christian Bowers, and Director Rohit Aggarwal, discuss how pharma companies are effectively combining and analyzing data to retrieve real-time, actionable insights for engaging with their customers to drive growth and improve patient outcome. This episode includes:
- Focusing on value and outcomes of treatment protocols and less on specific products.
- Gaining a better understanding of pharma customers and what drives their behaviors.
- Reaching beyond the barrier in driving differentiation amongst competitors.
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health with hosts Strategy& Principal, Igor Belokrinitsky, Health Industries Vice Chair, Jenny Colapietro and guests Josette Beran, Emily Anne Jacobstein and Hugo Pariseau as they discuss a more coordinated approach to crisis management and emergency preparedness across health organizations. This episode includes:
- How the endurance of the pandemic impacted everything from long-term supply chain challenges to staffing and funding challenges
- Sharing lessons learned and applying them in order to enhance emergency preparedness
- Identifying key areas of spending to help health ecosystems prepare and prevent for future crises
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in health with hosts Strategy& Principal, Igor Belokrinitsky and Health Industries Vice Chair, Jenny Colapietro, who are joined by Hinge Health’s Director of Business Operations & Strategy, Audrey Meng, to discuss the changing landscape of healthcare today. This episode includes:
- How digital health innovation is driving hybrid healthcare models for everyone
- Building trust across the entire ecosystem
- Developing diverse and inclusive care strategies to meet the needs of all patients
Tune in to this episode of PwC's Next in Health with hosts Strategy& Principal, Igor Belokrinitsky and Health Industries Vice Chair, Jenny Colapietro, who are joined by PwC's Health Strategy Director, Pia Bhatia, to discuss how health organizations are incorporating digital capabilities to transform their organizations. This episode includes:
- How to measure success
- Business units that are ready to perform
- Creating a portfolio approach to innovation
- Engaging with the external ecosystem to achieve greater opportunities
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC's Aparna Kumar and John Capalbo, on the future of Academic Medical Centers. This episode includes:
- Rising challenges facing Academic Medical Centers
- Addressing the constraints for resources and talent
- New strategies for the future of Academic Medical Centers and the communities they serve
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Strategy& Director, Sierra Hawthorne, on the foundational role trust plays to improve the quality of healthcare. This episode includes:
- How trust influences different communities' perception of healthcare
- Essential building blocks to help rebuild the loss of trust
- Behaviors, strategies and data and technology that institutions can leverage to help cultivate a culture of trust
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, discuss whether the U.S. health industry is prepared to meet the challenges of a future pandemic. This episode highlights:
- Adapting lessons learned from the COVID-19 pandemic to reimagine and strengthen the health industry
- Bridging access gaps to advance health equity in underserved communities
- Building and maintaining public trust during and post COVID-19
- Emerging pandemic-driven trends
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Principals Paul Leinwand and Matt Mani, on the seven leadership imperatives for success, in their new book Beyond Digital: How Great Leaders Transform Their Organizations and Shape the Future. This episode highlights:
- The strategies and concepts behind the Beyond Digital book to help companies transform in the new digital era
- How the health industry can benefit from the success stories shared by leading organizations to deliver value and purpose
- Cleveland Clinic’s journey to reinventing their health ecosystem to empower their people
- Inverting the leadership model
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Principal, Namit Mehta and PwC Strategy& Senior Director, Rohit Harve, on the future of cutting-edge gene and cell therapies. This episode includes:
- Addressing the value and impact of gene cell therapy to improve the quality of life
- Challenges and opportunities with the adoption of a gene cell therapy operating models
- Solutions and emerging technologies health organizations should consider in their approach to deliver gene cell therapies
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with the Vice President of Strategy, Growth & Innovation at Optum, K. R. Prabha, on engaging physicians to lead change in the healthcare ecosystem. This episodes includes:
- Prabha’s diverse journey as a healthcare leader and key considerations that can improve health systems
- The shift in digital technology and other factors that heighten the importance of upskilling healthcare workers
- Challenges and opportunities with the rise of telehealth
- How a multi-faceted approach can help in addressing healthcare issues today
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Strategy& Principals Rick Edmunds and Shaguna Punj, on how pharmaceutical and life sciences companies can use value-based planning as a tool to make better choices to get better results. This episodes includes:
- How the current and future environment is influencing choices that pharma and life sciences companies must make
- Decision-making methodologies that can bring more clarity and control to organizations
- Practical steps to apply value-based planning to organizations
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC's Global Pharmaceutical and Life Sciences Cyber Leader, Nalneesh Gaur and PwC's Cybersecurity Principal, Robbie Higgins, on cybersecurity issues and privacy laws that pharmaceuticals and life sciences companies are dealing with in China. This episode includes insights and implications of:
- China Cybersecurity Law
- Multi-layer Protection Scheme 2.0
- Data Security Law
- Personal Information Protection Law
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Director, Rohit Nayak, PwC Strategy& Senior Manager, Sri Murthy Guru and PwC Strategy& Senior Associate, Cailin Hong, on what physicians are seeking from payers, health systems and management services organizations (MSOs), to help improve the practice of medicine. This episode includes:
- Emerging business models and solutions that can enhance the physician experience
- The role of payers and providers in driving physician enablement within the health ecosystem
- Actions health organizations should consider to help support and encourage their physicians
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on current deal trends impacting the health sector. This episode includes:
- Significant mergers and acquisitions of 2021
- Future deal drivers for 2022 and the potential impact on current trends
- Deal growth activity in healthcare and pharma & life sciences subsectors
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Director, Sierra Hawthorne, PwC Strategy& Managing Director, Josette Beran, and The PwC Katzenbach Center Managing Director, Reid Carpenter, on the current state of the health industry and three trends to watch for in 2022, including:
- Investing in our workforce
- Building trust
- Creating financial sustainability
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with the Founder & CEO of Concert Health, Spencer Hutchins, on the evidence-based health care model that will help tighten the gaps in our behavioral and mental health services. This episode includes:
- How Concert Health’s collaborative care model addresses issues around healthcare access and integration
- The importance of integration and partnerships with providers and payors in addressing behavioral health
- Leveraging data and analytics to drive growth and innovation in behavioral health services
- Key considerations to reduce racial disparities and prevent burnout in behavioral health care
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Omar Chane, and PwC Managing Director, Amy Hunckler, on the evolution of the vaccines market and mRNA technology, including:
- The impact of new entrants on the vaccine industry
- Manufacturers' role in improving the customer experience
- How mRNA and its various applications will continue to shape the pharmaceutical and life sciences industry
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC's Pharmaceutical and Life Sciences Research and Development Principals, Anup Kharode and Brian Slizgi, on the evolution of the clinical trial delivery model, including:
- Impact of COVID-19 on clinical trials and research
- Emerging trends and disruptors
- Implications for clinical research organizations (CROs) and the broader pharmaceutical industry
- The future of decentralized clinical trials
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Director, James Lin, on price transparency regulations , including:
- Key implications and considerations for payers, providers and pharma and life sciences
- Impacts to consumer behavior and market pricing
- How to improve the relationship between price and quality transparency
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC’s Consulting Solutions Director, Aparna Kumar, on how the next generation is transforming philanthropy to drive organizational success and social change, including:
- The current philanthropic funding landscape
- Benefits of strategic partnerships
- The role of technology in shaping the future of philanthropy
- Bridging the relationship between philanthropy and ESG
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Kevin McLellan, on the latest medical device trends and innovations, including:
- Shifting consumer and patient engagement
- Implications of connected devices and data on care experience
- Differentiated growth opportunities for medical technology to unlock value and reimagine tradition care model
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Paul Leinwand, PwC Director, Inshita Wij and PwC Senior Manager, Lauren Christian, on recent consumer healthcare survey findings, including:
- What consumers are seeking from their healthcare experience and how health systems can respond
- Must-haves for improving consumer experience and loyalty
- The demand for virtual care persists
- Future considerations for health organizations to increase consumer engagement
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, on the long-respected history of bloodletting, including:
- Barber surgeons and early medicine
- The practice and evolution of bloodletting
- The influence of ancient principles on modern medicine
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Partner, Derek Gaasch, on how health insurance companies can optimize their member engagement, to help them achieve better health, including:
- The consumerization of health
- The importance of advocacy for members and health insurers
- Proactive efforts to increase members’ health and wellness engagement
- Technology’s impact on member advocacy
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Director, Kristin Craig, on the evolution of delivering acute care at home, including:
- Defining the home-hospital care model
- The current home-hospital care landscape and the economic, operational, and clinical implications for health systems
- Potential tailwinds and headwinds of home-hospital care
- The future of home-hospital care
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, in discussion with PwC Principal Katie Burg Plaza, on how health organizations can combat and prevent provider burnout and staffing shortages, including:
- Implications of provider burnout on the healthcare industry prior to COVID-19
- Downstream impacts of provider burnout on staffing, patient care and operations
- Short and long-term considerations for employee retention across care continuum
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Clinical Transformation Managing Director, Lorie Wijntjes, on the impact of greater clinical trial diversity and inclusion with the advancement of health research, including:
- Why is it important to ensure clinical trials have diverse participants?
- How are pharmaceutical companies addressing the lack of diversity?
- What are the barriers to increasing diversity and inclusion?
- Who are the stakeholders in clinical research?
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Health Industries Trust Solutions Leader, Laura Robinette, on the role of environmental, social, and governance (ESG) in deals for the health industry, including:
- The importance of having an ESG deals strategy for health organizational success
- What best practices and lessons learned from other organizations can be applied?
- Are health leaders eager to adopt an ESG deals framework?
- How can health organizations prepare for an ESG deals strategy integration?
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with HRI's Crystal Yednak, on the results of PwC's Pulse survey and the future of work for healthcare organizations and pharmaceutical companies, including how leaders are considering and navigating decisions around:
- Varying return to work plans
- Workforce shortages
- Flexible and hybrid workforce models
- Employee vaccine mandates
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Consulting Solutions Director, Aparna Kumar, on how the U.S. can overcome the shortage of healthcare workers, including:
- Physician workforce projections released in The Association of American Medical Colleges’ (AAMC) annual report
- The pandemic’s impact on the physician shortages
- Decreasing regulatory barriers for internationally educated physicians could ease the burden of physician shortages
- Short-term strategies to address physician workforce shortages
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Carrum Health’s CEO, Sachin Jain and SVP of Provider Partnerships, Christoph Dankert, on healthcare marketplace and delivery transformation, including:
- The role of value based care and price transparency in addressing current state issues such as physician incentive misalignment
- The impact of shifting power, behavior and quality dynamics between providers, payers, employers and consumers
- The role of bundles, and the influence of data and technology, in driving meaningful prices, quality of care and the overall healthcare experience
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on the current deals activity impacting the health sector, including:
- Tailwinds that are driving sector deals activity and growth
- Headwinds that pose challenges for deals activity
- Factors that can influence merger and acquisition success
- Healthcare deals landscape outlook
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Pharmaceutical Quality Partner, Jan Paul Zonnenberg, on the importance of drug quality in the health ecosystem, including:
- The history and current state of pharmaceutical quality in the U.S.
- Patient trust and quality in the drug development ecosystem
- What forces are accelerating quality improvements?
- The role of culture in improving drug quality
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, discuss how consumers are accessing their healthcare post pandemic, including:
- Challenges and implications of differing perspectives among provider executives and consumers on virtual health
- Considerations for delivering a personalized virtual health experience
- New entrants' role in shaping the health system
- Importance and influence of consumer preferences in optimizing the care delivery experience
Tune into this episode of PwC's Next in Health to hear PwC US Healthcare Technology Consulting Leader Will Perry, in discussion with Microsoft’s Chief Medical Officer, Dr. David Rhew, on how technology is fundamentally changing how healthcare is designed and delivered, including:
- What role does Microsoft play in the health ecosystem?
- The importance of digital channels and engagement
- Consumer digital health journey
- Predictive analytics and the future of healthcare
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, discuss medical cost trend for 2021 and expectations for 2022, including:
- The impact of COVID-19
- Projections for the coming year
- The effects of deferred care and intervention
- The need for investments in forecasting and predictive modeling
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Health Industries Principal, Abbas Mooraj, on how cloud enables healthcare organizations to harness data and analytics, including:
- Current cloud-based investments for providers
- Future of the healthcare system’s cloud journey
- Enterprise cloud computing’s return on investment
- Leveraging cloud technologies to adopt a more patient-centric healthcare system
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, in discussion with PwC’s Health Services Principal, Claudia Douglass, on the future of telehealth in a post COVID-19 world, including:
- The current state of telehealth
- Different types of telehealth services
- Connected diagnostic devices and technical infrastructure requirements
- Designing a more consumer-centric telehealth experience
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos cover a roundup of the latest COVID-19 headlines and trends, including:
- Preventing the next pandemic with infectious disease forecasting
- Global vaccine passports
- Vaccine lotteries and incentives within the United States,COVID-19 variants, including B.1.1.7
- U.S. government subsidized health coverage
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos, in discussion with PwC’s HIA Operations Strategy Principal, Namit Mehta, and PwC's Cyber Security Principal, Robbie Higgins, on how organizations can build resiliency and plan for future potential supply chain disruptions, including:
• Importance of scenario planning in building resiliency
• Organizational interventions to consider and/or prioritize to secure the supply chain
• Steps for organizations to take to begin scenario planning
• Future technologies and their impact on the future health system
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos, discuss the risks employers should be aware of, if they decide to adopt a vaccine mandate in the workplace, including:
• Whether employers can require employees to be vaccinated?
• The influence that federal, state and local laws may have on employer mandates
• Different types of employer incentives to encourage employee vaccinations
• The history and growing controversy surrounding vaccine passports
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos, provide an update on the continued challenges we are experiencing due to COVID-19, including:
- COVID-19 reaches Mount Everest
- The current job outlook for healthcare providers in the U.S.
- Will the proposed TRIPS Agreement waiver, aid in equitable distribution of the COVID-19 vaccines in low-income countries?
- How can we encourage people to get vaccinated?
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos in discussion with PwC’s Strategy& Partner, Will Nolen, on why quality improvement in healthcare is important, including:
- The differing definitions of healthcare quality among stakeholders and consumers across the ecosystem
- The association between healthcare quality and costs
- The importance of designing more consumer centric quality offerings through technology and innovation
- The significance of archetypes in the quality of healthcare
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC’s Deals Strategy & Pharma and Life Sciences Principal, Claire Love, on what role private equity firms play, in the rapid growth market of gene and cell therapies, including:
- What are the growth drivers for private equity firms?
- What technologies and innovations can be leveraged to increase supply chain efficiency?
- Opportunities and risks private equity firms should consider
- Improving collaboration between the pharmaceutical industry and private equity investors
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, discuss parents' willingness to vaccinate their kids and the impact on public health's strategy with the vaccine roll out, including:
- Differing vaccine hesitancy attitudes amongst parents
- Correlations between parents’ vaccinating themselves and their children
- The influence of demographics-race, income, education, age, location-on vaccination hesitancy and parents’ decision to vaccinate children
- Why parents are more skeptical about vaccines than those without children
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, discuss how to test yourself at-home for COVID-19 and more, including:
Overview of the at-home DIY COVID-19 testing process
How can we empower our healthcare workforce to combat burnout?
Vaccination update in the U.S.
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC Strategy&, Sundar Subramanian, on the future health ecosystems and how health leaders will need to completely rethink their strategic footprint to be successful, including:
- Impact of digitization on the health ecosystem
- Emerging key business models health organizations should consider
- Impact and value delivered by a consumer centric health system versus a traditional health system
- Potential changes to the Affordable Care Act and implications for the health ecosystem
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the pandemic’s long-term effects on the health industry, including:
- Excess deaths stemming from COVID-19 and other causes in the U.S.
- The pandemic’s impact on emergency department (ED) visits
- Consumers’ increasing willingness to seek adoption of alternative medical care
- How to address the uptick in behavioral health cases among Black Americans and other health disparities
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the vaccine rollout and COVID-19 treatments, including:
- History, digitization and the politics surrounding vaccine passports
- Employers' approach with vaccine mandates and the future of work
- DIY rapid testing
- Increasing consumer comfort with receiving care through 'non-traditional' means (i.e., home health, urgent care, retail)
- Clinical trials in adolescents
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, discuss what the health industry could do differently if faced with another pandemic, including:
- The health system’s strengths and weaknesses exposed by the pandemic
- The American Rescue Plan Act of 2021’s impact on the economy
- Digital health investment opportunities post pandemic
- Supply chain resiliency
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur in discussion with PwC’s Strategy& Principal, Igor Belokrinitsky, on how the pandemic is accelerating change in the health industry, including:
- The impact of more connected and collaborative health ecosystems
- Emerging archetypes health organizations should consider
- How health disparities are being addressed and giving rise to a more empowered consumer
- Innovation in the health industry
Tune into this episode of PwC's Next in Health to hear Health Research Institute (HRI) leader, Benjamin Isgur, and HRI Regulatory Center leader, Trine Tsouderos in discussion with HRI's Crystal Yednak, on the new price transparency and impacts to healthcare stakeholders, including:
- What do the new rules mean for providers and payers?
- How will providers and payers use the newly available pricing data in upcoming negotiations?
- How can consumers use this information?
- What are the implications of these new rules on new entrants?
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, discuss how COVID-19 is changing the healthcare industry, including:
- COVID-19 vaccine hesitancy amongst healthcare workers
- Impact of the Centers for Medicare & Medicaid Services (CMS) expansion on Medicare telehealth services
- Medicare Payment Advisory Commission (MedPAC)'s findings on utilization and revenue disruption for providers
- Uneven recovery of healthcare jobs amid pandemic
Tune into this episode of PwC's Next in Health to hear Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC’s US Pharmaceutical and Life Sciences Leader, Glenn Hunzinger; on the top health industry issues of 2021; for pharmaceutical and life sciences companies, including:
- Current industry landscape
- Pharmaceutical & Life sciences deals outlook
- Supply chain management and predictive technologies
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, reflect on the pandemic’s one year mark and where we are now, including:
- The Advisory Committee on Immunization Practices (ACIP) issues vaccine rollout recommendations and safety guidelines
- Considerations for mRNA COVID-19 vaccines’ dosing intervals
- The Centers for Disease Control and Prevention (CDC)’s V-safe vaccine reporting system
- Learnings from past pandemics
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the latest vaccine authorized by the Food and Drug Administration (FDA) for emergency use, including:
- Vaccine clinical trials and the efficacy rate on COVID-19 related infections
- Expected uptick in the overall vaccine supply
- Existing COVID-19 vaccines’ effectiveness on COVID-19 variants
- FDA’s updated guidance to address vaccines and emerging COVID-19 variants
Tune into this episode of PwC's Next in Health to hear Health Research Institute (HRI) leader, Benjamin Isgur, and HRI Regulatory Center leader, Trine Tsouderos in discussion with HRI's Erin McCallister on what pharma might expect from federal agencies, including:
- Food and Drug Administration (FDA)'s potential to broaden / standardized policies implemented in response to the pandemic (i.e., clinical trial diversity, supply chain visibility)
- How politics has impacted FDA productivity
- Centers for Medicare & Medicaid Services (CMS)' approach to control drug spending
- Health and Human Services' role in 340B changes
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
- COVID-19 treatments and impact to COVID-19-related hospitalizations and deaths
- Improvement in the vaccination rates in the U.S.
- Vaccine distribution and lessons learned from non-traditional companies
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC's Health Services leader, Gurpreet Singh, on the top health industry issues of 2021, including the impacts of:
- Accelerated digital capabilities
- Better predictive healthcare forecasting
- Increased collaboration on experience across the ecosystem (consumers, payers, providers, pharma)
- Redesigned supply chain models
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on COVID-19 vaccine distributions, including:
- Average volume of vaccine distributions in the U.S. as compared with other countries
- Racial and ethnic disparities in vaccination rollout
- Future equity considerations as major retail pharmacies prepare to distribute vaccines
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the emerging SARS-CoV-2 variants, including:
- United Kingdom (B.1.1.7)
- South Africa (B.1.351)
- Japan / Brazil (P.1)
- Recommended steps to limit the spread of the various variants
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC's Health Industries leader, Karen Young, on the top health industry issues of 2021, including:
• Physician v. consumer experiences with telehealth
• Digitization of clinical trials
• Steps organizations can take to address health inequity
• The pandemic's impact on mental health
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• How to strengthen the vaccine supply chain
• Considerations for vaccine eligibility and distribution sites
• Infrastructure to prepare for the next pandemic
• New Occupational Safety and Health Administration (OSHA) guidance on COVID-19 worker protections
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• Parallels between COVID vaccine waiting lines v. historical H1N1 vaccine waiting lines
• Potential increase in non-COVID deaths if individuals do not have as much access to the necessary intensive care
• What insights are provided (or not) by current vaccination data
• President Biden’s $1.9t stimulus proposal
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• Provider healthcare jobs
• Flu season activity
• The United Kingdom variant from a public health and science lens
• The latest challenges with vaccine distribution
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on key items within the stimulus bill including::
• Surprise medical billing
• Price transparency
• Provider relief funds
• COVID-19 funding and more
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• Vaccine distribution
• Implications for payers and providers
• Implications for employers
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• What caused the current surge?
• Medicaid cuts coming? State budgets shrinking and a slowing job market
• Vaccine and timeline along with prioritization
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and a Health Research Institute Regulatory Center director, Sarah Haflett, provide an update on:
• How we conduct consumer research based on demand
• Mental and Virtual Health
• Vaccines
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• President elect - Joe Biden's health plan and what it means for the health
industry and for consumers
• Mink SARS-CoV-2
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• COVID 19: Voting Day 2020 during a pandemic
• Therapeutics Update
• HRI modeled the impacts of a nearly full repeal of the ACA, the fate will be decided by SCOTUS next year
"Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• COVID 19 and reopening of field hospitals in U.S. and Europe
• Studies on hospitalized patients and the less likeliness to die from COVID 19
• FDA Vaccines and Related Biologic Products Advisory Committee (VRBAC)"
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• COVID 19: A global look at the pandemic and what other countries are experiencing
• New data on treatments and their effectiveness
• A deep dive into the challenges of turning vaccines into vaccinations
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• Fall surge and is SARS-CoV-2 seasonal?
• Update on COVID-19 and young people
• Positive news on non-pharmaceutical interventions and therapeutics
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• Global snapshot - what is happening with COVID- 19 in the southern hemisphere?
• Medicaid enrollment - with unemployment rising where are people getting coverage?
• Therapeutics in the hospitals - what treatments are on the rise?
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on:
• Global snapshot - COVID- 19 and Brazil
• Fall in the U.S. and reopening of schools
• Serology analysis
• Demographics of the virus
Tune into this episode of PwC's Next in Health to hear Health Research Institute Leader, Benjamin Isgur, and Health Research Institute Regulatory Center Leader, Trine Tsouderos, provide an update on:
• COVID-19 vaccines and the ongoing trials
• Erosion of trust with the vaccination trial process
• The complicated distribution plan required to vaccinate Americans
Tune into this episode of PwC's Next in Health to hear our Health Research Institute Leader, Benjamin Isgur, talk to Trine Tsouderos, Health Research Institute Regulatory Center Leader, about the impact the pandemic has had on:
- jobs in the health sector
- the economic downturn impact on consumption and access to care
- implications for the entire health sector
Tune into this episode of PwC's Next in Health to hear our Health Research Institute Leader, Benjamin Isgur, and Trine Tsouderos, Health Research Institute Regulatory Center Leader, discuss what is a super spreading event and they share findings from an antibodies immunity study from Iceland as well as provide a COVID-19 vaccine and treatment update.
Tune into this episode of PwC's Next in Health to hear our Health Research Institute Leader, Benjamin Isgur, talk to Trine Tsouderos, Health Research Institute Regulatory Center Leader, address how a person's race disproportionately impacts the experience and risk associated with COVID-19 in the United States.
Tune into this episode of PwC's Next in Health to hear our Health Research Institute Leader, Benjamin Isgur, talk to Trine Tsouderos, Health Research Institute Regulatory Center Leader, about the various types of COVID:19 tests that are available. Trine will explain why there are different tests, how they are administered and what they are used for.
Tune into this episode of PwC's Next in Health to hear our Health Research Institute Leader, Benjamin Isgur, talk to Trine Tsouderos, Health Research Institute Regulatory Center Leader, about how people of different ages have been impacted. As the pandemic has unfolded, children once thought largely immune to the virus have started testing positive in large numbers.
Tune into this episode of PwC's Next in Health to hear our Health Research Institute leader, Benjamin Isgur, talk to Trine Tsouderos, Health Research Institute Regulatory Center Leader, about what's happening with COVID-19 cases and hospitalizations in the United States, news about convalescent plasma treatments being tested and the pandemic's impact on mental health.